Key result
Left ventricular assist device implantation and subsequent corticosteroid and immunosuppressive therapy led to remission and recovery of left ventricular ejection fraction from 6% to 68%.
Why the study?
Does LVAD combined with corticosteroid and immunosuppressive therapy improve LVEF and clinical status in a patient with fulminant giant cell myocarditis associated with polymyositis?
Case Report (n=1)
No
Does LVAD combined with corticosteroid and immunosuppressive therapy improve LVEF and clinical status in a patient with fulminant giant cell myocarditis associated with polymyositis?
LVAD implantation followed by corticosteroid and immunosuppressive therapy can lead to successful recovery and remission in fulminant giant cell myocarditis associated with polymyositis.
Answers are grounded in this paper and cite their sources.
May support recovery in fulminant giant cell myocarditis; hypothesis-generating and requires prospective validation before practice change.
A 58-year-old man with a recent history of generalized myalgia and muscle weakness was transferred to our hospital because of acute progressive dyspnea. The patient underwent left ventricular (LV) assist device (LVAD) implantation due to cardiogenic shock with a LV ejection fraction (LVEF) of 6%. The histological findings obtained from LV apex showed the infiltration of multinucleated giant cells and severe myocardial contusion. Combining this histological finding with our experienced neurologists comments, resulted in a final diagnosis of fulminant giant cell myocarditis associated with polymyositis. A day after LVAD implantation, the patient received corticosteroid and immunosuppressive therapy, and the LVEF recovered to 68%.
No takes yet. Share an insight, caveat, or question.
Ooka et al. (2017) conducted a case report in Fulminant giant cell myocarditis associated with polymyositis (n=1). Left ventricular assist device (LVAD) and subsequent corticosteroid and immunosuppressive therapy was evaluated on Left ventricular ejection fraction (LVEF) recovery. Left ventricular assist device implantation and subsequent corticosteroid and immunosuppressive therapy led to remission and recovery of left ventricular ejection fraction from 6% to 68%.
Synapse has enriched 10 related papers. Consider them for comparative context: